Shawn Zinnen

Title: Shawn Zinnen - Innovator in Bone-Targeting Therapeutics

Introduction

Shawn Zinnen is an inventor based in Aurora, CO (US). He is currently associated with Mbc Pharma, Inc. Although he does not hold any granted patents, his work focuses on innovative therapeutic methods for treating bone-related diseases.

Latest Patent Applications

Shawn Zinnen has contributed to several notable patent applications. One of his latest applications is titled "Drug Combination Treatments Using Bone-Targeting Therapeutics for Bone and Bone-Related Disease." This application presents a novel method for creating fixed, non-antagonistic molar ratios of drugs in and around the bone environment for desired periods of time. The method aims to treat bone and bone-related diseases by administering a pharmaceutical composition that includes a bone-targeted therapeutic agent capable of releasing a drug payload from the bone surface, along with a second therapeutic agent. This approach is particularly useful for conditions such as cancer-induced bone disease, osteomyelitis, bone infections, bone pain, inflammatory bone disease, and metabolic diseases.

Another significant application is "Compositions and Methods for Treatment of Distentable Tissues." This application outlines compositions and methods for treating cancer in distentable tissues, such as the bladder, uterus, peritoneum, omentum, or eye. The useful compositions include DT-EGF fusion proteins as described in the application.

Conclusion

Shawn Zinnen is making strides in the field of bone-targeting therapeutics, focusing on innovative methods to address significant medical challenges. His contributions through patent applications reflect his commitment to advancing treatment options for bone-related diseases.